Mayo Clinic Phage Program Biobank
Enrolling by invitation
Conditions studied: Bacteriophage Therapy
In brief
The purpose of this study is to help scientists and clinicians discover answers to research questions related to antibiotic-resistant bacterial infections, and the role that phage therapy plays as a possible treatment.
Key facts
- Study ID
- NCT05314426
- Run by
- Mayo Clinic
- People needed
- 100
- Starts
- 2022-04-19
- Expected to finish
- 2027-04-01
- Last updated by the study team
- 2026-06-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ≥ 18 years of age.
- Able to provide informed consent.
- Individual must have a future treatment plan to receive or has historically received phage therapy.
You may not qualify if…
- Individuals , 18 years of age.
- Unwilling/unable to provide informed consent.
Where it is running
- Mayo Clinic Rochester — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.